documents: FDA-2022-N-2390-0610

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2390-0610 FDA FDA-2022-N-2390 12 - Vanda Pharmaceuticals FDA Update for HETLIOZ in the Treatment of Jet Lag Disorder Supporting & Related Material Background Material 2026-05-20T04:00:00Z 2026 5     2026-05-20T15:36:00Z   0 0 09000064b92e07c1

Links from other tables